Therefore, we hypothesized that tk-MCP-1 fusion gene could significantly enhance the efficacy of suicide gene therapy contributed by the direct antitumor activity and the elicited anti-tumor immunity in ovarian cancer. This evidence concerns the gene CCL2 and ovarian cancer.